The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Revitalizing membrane rafts: new tools and insights
Simons, K., & Gerl, M. J. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2977 · Cited by 1,234
High density lipoprotein metabolism.
Eisenberg, S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37713-0 · Cited by 1,210
Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol
Cohen, J. C., Kiss, R. S., Pertsemlidis, A., Marcel, Y. L., McPherson, R., & Hobbs, H. H. (2004) · Science · doi:10.1126/science.1099870 · Cited by 1,108 · cited 1×
“Genetic determinants of cholesterol efflux Allelic variations in ABCA1 , APOA1 , and LCAT have been identified as causes of low HDL-cholesterol levels”
BackgroundVaisar, T., Pennathur, S., Green, P. S., Gharib, S. A., Hoofnagle, A. N., Cheung, M. C., Byun, J., Vuletic, S., Kassim, S., Singh, P., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci26206 · Cited by 942 · cited 1×
“With the use of mass-spectrometry-based proteomics, Vaisar and colleagues identified 48 different proteins in HDL isolated from healthy individuals and patients with CHD”
MethodInazu, A., Brown, M. L., Hesler, C. B., Agellon, L. B., Koizumi, J., Takata, K., Maruhama, Y., Mabuchi, H., & Tall, A. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231803 · Cited by 861
Fogelman, A. M., Shechter, I., Seager, J., Hokom, M., Child, J. S., & Edwards, P. A. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.4.2214 · Cited by 849
Self-citationVan Lenten, B. J., Hama, S. Y., de Beer, F. C., Stafforini, D. M., McIntyre, T. M., Prescott, S. M., La Du, B. N., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118345 · Cited by 840
Self-citationNavab, M., Imes, S. S., Hama, S. Y., Hough, G. P., Ross, L. A., Bork, R. W., Valente, A. J., Berliner, J. A., Drinkwater, D. C., & Laks, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115532 · Cited by 737
Self-citationZheng, L., Nukuna, B., Brennan, M.-L., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421109 · Cited by 737
Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune Responses
Yvan-Charvet, L., Wang, N., & Tall, A. R. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179283 · Cited by 680
Navab, M., Hama, S. Y., Anantharamaiah, G. M., Hassan, K., Hough, G. P., Watson, A. D., Reddy, S. T., Sevanian, A., Fonarow, G. C., & Fogelman, A. M. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33462-3 · Cited by 668
Self-citationThe role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis
Rader, D. J., Alexander, E. T., Weibel, G. L., Billheimer, J., & Rothblat, G. H. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800088-jlr200 · Cited by 597
Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo
Wang, X., Collins, H. L., Ranalletta, M., Fuki, I. V., Billheimer, J. T., Rothblat, G. H., Tall, A. R., & Rader, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32057 · Cited by 593
Ansell, B. J., Navab, M., Hama, S., Kamranpour, N., Fonarow, G., Hough, G., Rahmani, S., Mottahedeh, R., Dave, R., Reddy, S. T., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103624.14436.4b · Cited by 590
Self-citationBhattacharyya, T. (2008) · JAMA · doi:10.1001/jama.299.11.1265 · Cited by 533
Braun, A., Trigatti, B. L., Post, M. J., Sato, K., Simons, M., Edelberg, J. M., Rosenberg, R. D., Schrenzel, M., & Krieger, M. (2002) · Circulation Research · doi:10.1161/hh0302.104462 · Cited by 492
Briel, M., Ferreira-Gonzalez, I., You, J. J., Karanicolas, P. J., Akl, E. A., Wu, P., Blechacz, B., Bassler, D., Wei, X., Sharman, A., et al. (2009) · BMJ · doi:10.1136/bmj.b92 · Cited by 491 · cited 1×
“222" language="eng" relation="no"> Introduction Epidemiological studies from the past five decades have consistently shown that levels of HDL cholesterol are inversely correlated with clinical events resulting from atherosclerosis, whereas LDL-cholesterol levels are directly related to the rate at which these events o…”
BackgroundCastrillo, A., Joseph, S. B., Vaidya, S. A., Haberland, M., Fogelman, A. M., Cheng, G., & Tontonoz, P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00384-8 · Cited by 488
Self-citationOxidized LDL: Diversity, Patterns of Recognition, and Pathophysiology
Levitan, I., Volkov, S., & Subbaiah, P. V. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2733 · Cited by 473
Bergt, C., Pennathur, S., Fu, X., Byun, J., O'Brien, K., McDonald, T. O., Singh, P., Anantharamaiah, G. M., Chait, A., Brunzell, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405292101 · Cited by 454
Inflammation Impairs Reverse Cholesterol Transport In Vivo
McGillicuddy, F. C., de la Llera Moya, M., Hinkle, C. C., Joshi, M. R., Chiquoine, E. H., Billheimer, J. T., Rothblat, G. H., & Reilly, M. P. (2009) · Circulation · doi:10.1161/circulationaha.108.810721 · Cited by 391
de la Llera-Moya, M., Drazul-Schrader, D., Asztalos, B. F., Cuchel, M., Rader, D. J., & Rothblat, G. H. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.199158 · Cited by 386
van der Steeg, W. A., Holme, I., Boekholdt, S. M., Larsen, M. L., Lindahl, C., Stroes, E. S. G., Tikkanen, M. J., Wareham, N. J., Faergeman, O., Olsson, A. G., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.060 · Cited by 374
Navab, M., Hama, S. Y., Cooke, C. J., Anantharamaiah, G. M., Chaddha, M., Jin, L., Subbanagounder, G., Faull, K. F., Reddy, S. T., Miller, N. E., et al. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33461-1 · Cited by 362
Self-citationNavab, M., Hama, S. Y., Hough, G. P., Subbanagounder, G., Reddy, S. T., & Fogelman, A. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31582-0 · Cited by 334
Self-citationThe metabolism and anti-atherogenic properties of HDL
Rye, K.-A., Bursill, C. A., Lambert, G., Tabet, F., & Barter, P. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800034-jlr200 · Cited by 331
High-Density Lipoprotein Loses Its Anti-Inflammatory Properties During Acute Influenza A Infection
Van Lenten, B. J., Wagner, A. C., Nayak, D. P., Hama, S., Navab, M., & Fogelman, A. M. (2001) · Circulation · doi:10.1161/01.cir.103.18.2283 · Cited by 324
Self-citationNavab, M., Anantharamaiah, G. M., Reddy, S. T., Hama, S., Hough, G., Grijalva, V. R., Wagner, A. C., Frank, J. S., Datta, G., Garber, D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134275.90823.87 · Cited by 323
Self-citationMildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
Navab, M., Hama-Levy, S., Van Lenten, B. J., Fonarow, G. C., Cardinez, C. J., Castellani, L. W., Brennan, M. L., Lusis, A. J., Fogelman, A. M., & La Du, B. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119369 · Cited by 309
Self-citationAntiatherogenic function of HDL particle subpopulations: focus on antioxidative activities
Kontush, A., & Chapman, M. J. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833bcdc1 · Cited by 293
Haptoglobin: Basic and Clinical Aspects
Levy, A. P., Asleh, R., Blum, S., Levy, N. S., Miller-Lotan, R., Kalet-Litman, S., Anbinder, Y., Lache, O., Nakhoul, F. M., Asaf, R., et al. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2793 · Cited by 293
Bloedon, L. T., Dunbar, R., Duffy, D., Pinell-Salles, P., Norris, R., DeGroot, B. J., Movva, R., Navab, M., Fogelman, A. M., & Rader, D. J. (2008) · Journal of Lipid Research · doi:10.1194/jlr.p800003-jlr200 · Cited by 292
Self-citationModification of High Density Lipoprotein by Myeloperoxidase Generates a Pro-inflammatory Particle
Undurti, A., Huang, Y., Lupica, J. A., Smith, J. D., DiDonato, J. A., & Hazen, S. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047605 · Cited by 266
High Density Lipoprotein Structure–Function and Role in Reverse Cholesterol Transport
Lund-Katz, S., & Phillips, M. C. (2010) · Subcellular Biochemistry · doi:10.1007/978-90-481-8622-8_7 · Cited by 262
ABCA1 and ABCG1 Protect Against Oxidative Stress–Induced Macrophage Apoptosis During Efferocytosis
Yvan-Charvet, L., Pagler, T. A., Seimon, T. A., Thorp, E., Welch, C. L., Witztum, J. L., Tabas, I., & Tall, A. R. (2010) · Circulation Research · doi:10.1161/circresaha.110.217281 · Cited by 217
McMahon, M., Grossman, J., Skaggs, B., FitzGerald, J., Sahakian, L., Ragavendra, N., Charles‐Schoeman, C., Watson, K., Wong, W. K., Volkmann, E., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24677 · Cited by 216
Zheng, L., Settle, M., Brubaker, G., Schmitt, D., Hazen, S. L., Smith, J. D., & Kinter, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407019200 · Cited by 207
Patel, S., Drew, B. G., Nakhla, S., Duffy, S. J., Murphy, A. J., Barter, P. J., Rye, K.-A., Chin-Dusting, J., Hoang, A., Sviridov, D., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.008 · Cited by 203
Wu, Z., Wagner, M. A., Zheng, L., Parks, J. S., Shy, J. M., Smith, J. D., Gogonea, V., & Hazen, S. L. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1284 · Cited by 201
Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans
Edmondson, A. C., Brown, R. J., Kathiresan, S., Cupples, L. A., Demissie, S., Manning, A. K., Jensen, M. K., Rimm, E. B., Wang, J., Rodrigues, A., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37176 · Cited by 192
Shao, B., Oda, M. N., Bergt, C., Fu, X., Green, P. S., Brot, N., Oram, J. F., & Heinecke, J. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600011200 · Cited by 191
Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I
Shao, B., Cavigiolio, G., Brot, N., Oda, M. N., & Heinecke, J. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802025105 · Cited by 189
Charles‐Schoeman, C., Watanabe, J., Lee, Y. Y., Fürst, D. E., Amjadi, S., Elashoff, D. A., Park, G. S. H., McMahon, M. A., Paulus, H. E., Fogelman, A. M., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24802 · Cited by 166
Self-citationHost-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy
Cruz, D., Watson, A. D., Miller, C. S., Montoya, D., Ochoa, M.-T., Sieling, P. A., Gutierrez, M. A., Navab, M., Reddy, S. T., Witztum, J. L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34189 · Cited by 161
Self-citationRECOMBINANT LIPOPROTEINS: Implications for Structure and Assembly of Native Lipoproteins
Atkinson, D., & Small, D. M. (1986) · Annual Review of Biophysics and Biophysical Chemistry · doi:10.1146/annurev.bb.15.060186.002155 · Cited by 158
Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I
Nobécourt, E., Tabet, F., Lambert, G. C., Puranik, R., Bao, S., Yan, L., Davies, M. J., Brown, B. E., Jenkins, A. J., Dusting, G. J., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.201715 · Cited by 154
Navab, M., Ananthramaiah, G. M., Reddy, S. T., Lenten, B. J. V., Ansell, B. J., Hama, S. Y., Hough, G., Bachini, E., Grijalva, V. R., Wagner, A. C., et al. (2005) · Annals of Medicine · doi:10.1080/07853890510007322 · Cited by 152
Self-citationCharakida, M. (2009) · JAMA · doi:10.1001/jama.2009.1346 · Cited by 152
Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype
Asleh, R., Blum, S., Kalet-Litman, S., Alshiek, J. A., Miller‐Lotan, R., Asaf, R., Rock, W., Aviram, M., Milman, U., Shapira, C., et al. (2008) · Diabetes · doi:10.2337/db08-0450 · Cited by 147
Shao, B., Pennathur, S., Pagani, I., Oda, M. N., Witztum, J. L., Oram, J. F., & Heinecke, J. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118182 · Cited by 142
HDL-inflammatory index correlates with poor outcome in hemodialysis patients
Kalantar‐Zadeh, K., Kopple, J. D., Kamranpour, N., Fogelman, A. M., & Navab, M. (2007) · Kidney International · doi:10.1038/sj.ki.5002491 · Cited by 139
Self-citationCell cholesterol homeostasis: Mediation by active cholesterol
Steck, T. L., & Lange, Y. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.08.007 · Cited by 139
Bielicki, J. K., Zhang, H., Cortez, Y., Zheng, Y. Y., Narayanaswami, V., Patel, A., Johansson, J., & Azhar, S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003665 · Cited by 134
Hoofnagle, A. N., & Heinecke, J. W. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900015-jlr200 · Cited by 128
Ibáñez, B., Vilahur, G., Cimmino, G., Speidl, W. S., Pinero, A., Choi, B. G., Zafar, M. U., Santos‐Gallego, C. G., Krause, B. R., Badimón, L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.071 · Cited by 126
Watanabe, J., Grijalva, V. R., Hama, S. Y., Barbour, K. W., Berger, F. G., Navab, M., Fogelman, A. M., & Reddy, S. T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.017202 · Cited by 126
Self-citationTabet, F., Remaley, A. T., Ségaliny, A. I., Millet, J. R., Yan, L., Nakhla, S., Barter, P. J., Rye, K., & Lambert, G. C. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.200196 · Cited by 121
HDL is the major lipoprotein carrier of plasma F2-isoprostanes
Proudfoot, J. M., Barden, A. E., Loke, W. M., Croft, K. D., Puddey, I. B., & Mori, T. A. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800607-jlr200 · Cited by 121
Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages
Smythies, L. E., White, C. R., Maheshwari, A., Palgunachari, M. N., Anantharamaiah, G. M., Chaddha, M., Kurundkar, A., & Datta, G. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00467.2009 · Cited by 120
HDL, lipid peroxidation, and atherosclerosis
Shao, B., & Heinecke, J. W. (2009) · Journal of Lipid Research · doi:10.1194/jlr.e900001-jlr200 · Cited by 117
Vaziri, N. D., Moradi, H., Pahl, M. V., Fogelman, A. M., & Navab, M. (2009) · Kidney International · doi:10.1038/ki.2009.177 · Cited by 117
Self-citationThe cholesterol controversy is over. Why did it take so long?
Steinberg, D. H. (1989) · Circulation · doi:10.1161/01.cir.80.4.1070 · Cited by 108
Coexistence of Foam Cells and Hypocholesterolemia in Mice Lacking the ABC Transporters A1 and G1
Out, R., Jessup, W., Le Goff, W., Hoekstra, M., Gelissen, I. C., Zhao, Y., Kritharides, L., Chimini, G., Kuiper, J., Chapman, M. J., et al. (2008) · Circulation Research · doi:10.1161/circresaha.107.161711 · Cited by 108
Double Superhelix Model of High Density Lipoprotein
Wu, Z., Gogonea, V., Lee, X., Wagner, M. A., Li, X., Huang, Y., Undurti, A., May, R., Haertlein, M., Moulin, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.039537 · Cited by 108
Lenten, B. J. V., Wagner, A. C., Navab, M., Anantharamaiah, G. M., Hama, S. Y., Reddy, S. T., & Fogelman, A. M. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700138-jlr200 · Cited by 103
Self-citationBaldán, Á., Bojanic, D. D., & Edwards, P. A. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800044-jlr200 · Cited by 98
Anti-Inflammatory Properties of Paraoxonase-1 in Atherosclerosis
Mackness, B., & Mackness, M. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-60761-350-3_13 · Cited by 98
Shao, B., Tang, C., Heinecke, J. W., & Oram, J. F. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m004085 · Cited by 97
Patel, S., Puranik, R., Nakhla, S., Lundman, P., Stocker, R., Wang, X., Lambert, G. C., Rye, K.-A., Barter, P. J., Nicholls, S. J., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.047 · Cited by 92
Increased HDL Cholesterol and ApoA-I in Humans and Mice Treated With a Novel SR-BI Inhibitor
Masson, D., Koseki, M., Ishibashi, M., Larson, C. J., Miller, S. G., King, B. D., & Tall, A. R. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.191320 · Cited by 92
Sethi, A. A., Sampson, M., Warnick, R., Muniz, N., Vaisman, B., Nordestgaard, B. G., Tybjærg-Hansen, A., & Remaley, A. T. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.139931 · Cited by 91
McGrath, K. C. Y., Li, X. H., Puranik, R., Liong, E. C., Tan, J. T. M., Dy, V., Bartolo, B. A. D., Barter, P. J., Rye, K.-A., & Heather, A. K. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.184663 · Cited by 90
Exchange of Apolipoprotein A-I between Lipid-associated and Lipid-free States
Cavigiolio, G., Geier, E. G., Shao, B., Heinecke, J. W., & Oda, M. N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.098434 · Cited by 88
Assignment of the Binding Site for Haptoglobin on Apolipoprotein A-I
Spagnuolo, M. S., Cigliano, L., D’Andrea, L. D., Pedone, C., & Abrescia, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411390200 · Cited by 87
Watanabe, J., Chou, K., Liao, J. C., Miao, Y., Meng, H.-H., Ge, H. Y., Grijalva, V. R., Hama, S. Y., Kozak, K., Buga, G. M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702163200 · Cited by 87
Self-citationAnti-inflammatory effects of apolipoprotein A-I in the rabbit
Patel, S., Bartolo, B. A. D., Nakhla, S., Heather, A. K., Mitchell, T. W., Jessup, W., Celermajer, D. S., Barter, P. J., & Rye, K.-A. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.05.035 · Cited by 82
The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats
Dai, L., Datta, G., Zhang, Z., Gupta, H., Patel, R. P., Honavar, J., Modi, S., Wyss, J. M., Palgunachari, M. N., Anantharamaiah, G. M., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m008086 · Cited by 71
Inflammation reduces HDL protection against primary cardiac risk
Corsetti, J. P., Gansevoort, R. T., Sparks, C. E., & Dullaart, R. P. F. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02287.x · Cited by 68
Yan, D., Navab, M., Bruce, C., Fogelman, A. M., & Jiang, X. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400053-jlr200 · Cited by 67
Self-citationCan dysfunctional HDL explain high coronary artery disease risk in South Asians?
Dodani, S., Kaur, R., Reddy, S. N., Reed, G. L., Navab, M., & George, V. T. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.12.019 · Cited by 66
Self-citationIncreased Oxidative Stress in Scavenger Receptor BI Knockout Mice With Dysfunctional HDL
Eck, M. V., Hoekstra, M., Hildebrand, R. B., Yaong, Y., Stengel, D., Kruijt, J. K., Sattler, W., Tietge, U. J. F., Ninio, E., van Berkel, T. J. C., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.145474 · Cited by 66
Prediction of human pharmacokinetics—biliary and intestinal clearance and enterohepatic circulation
Fagerholm, U. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.5.0001 · Cited by 62
Macrophage Reverse Cholesterol Transport in Mice Expressing ApoA-I Milano
Alexander, E. T., Weibel, G. L., Joshi, M. R., Vedhachalam, C., de la Llera-Moya, M., Rothblat, G. H., Phillips, M. C., & Rader, D. J. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.191379 · Cited by 56
Mechanism of Prebeta-HDL Formation and Activation
Chau, P., Nakamura, Y. K., Fielding, C. J., & Fielding, P. E. (2006) · Biochemistry · doi:10.1021/bi052535g · Cited by 54
Imaizumi, S., Grijalva, V. R., Navab, M., Lenten, B. J. V., Wagner, A. C., Anantharamaiah, G. M., Fogelman, A. M., & Reddy, S. T. (2010) · Drug Metabolism Letters · doi:10.2174/187231210791698438 · Cited by 54
Self-citationWoo, J. M. P., Lin, Z., Navab, M., Dyck, C. V., Trejo-Lopez, Y., Woo, K. M. T., Li, H., Castellani, L. W., Wang, X., Iikuni, N., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3020 · Cited by 54
Self-citationLipid Peroxidation and atherosclerosis
Wilson, R. B., & Newberne, P. M. (1976) · C R C Critical Reviews in Food Science and Nutrition · doi:10.1080/10408397609527212 · Cited by 51
Dynamics of Activation of Lecithin:Cholesterol Acyltransferase by Apolipoprotein A-I
Jones, M. K., Catte, A., Li, L., & Segrest, J. P. (2009) · Biochemistry · doi:10.1021/bi901242k · Cited by 49
Corsetti, J. P., Ryan, D., Rainwater, D. L., Moss, A. J., Zaręba, W., & Sparks, C. E. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.207977 · Cited by 48
Vedhachalam, C., Chetty, P. S., Nickel, M., Dhanasekaran, P., Lund‐Katz, S., Rothblat, G. H., & Phillips, M. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.126292 · Cited by 45
Wool, G. D., Cabana, V. G., Lukens, J. R., Shaw, P. X., Binder, C. J., Witztum, J. L., Reardon, C. A., & Getz, G. S. (2010) · The FASEB Journal · doi:10.1096/fj.10-165670 · Cited by 44
Gomaraschi, M., Baldassarre, D., Amato, M., Eligini, S., Conca, P., Sirtori, C. R., Franceschini, G., & Calabresi, L. (2007) · Circulation · doi:10.1161/circulationaha.107.705657 · Cited by 44
Khera, A. V., Wolfe, M. L., Cannon, C. P., Qin, J., & Rader, D. J. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.03.057 · Cited by 40
Skaggs, B. J., Hahn, B. H., Sahakian, L., Grossman, J. M., & McMahon, M. A. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.06.014 · Cited by 38
Gogonea, V., Wu, Z., Lee, X., Pipich, V., Li, X.-M., Ioffe, A., DiDonato, J. A., & Hazen, S. L. (2010) · Biochemistry · doi:10.1021/bi100588a · Cited by 38
Asleh, R., & Levy, A. P. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2829 · Cited by 37
Corsetti, J. P., Zaręba, W., Moss, A. J., Rainwater, D. L., & Sparks, C. E. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.09.012 · Cited by 36
The Antiatherogenic Function of HDL Is Impaired in Hyperhomocysteinemic Subjects
Holven, K. B., Aukrust, P., Retterstøl, K., Otterdal, K., Bjerkeli, V., Ose, L., Nenseter, M. S., & Halvorsen, B. L. (2008) · Journal of Nutrition · doi:10.3945/jn.108.090704 · Cited by 36
Peshavariya, H., Dusting, G. J., Bartolo, B. A. D., Rye, K.-A., Barter, P. J., & Jiang, F. (2009) · Free Radical Research · doi:10.1080/10715760903045304 · Cited by 33
Westerterp, M., Koetsveld, J., Yu, S., Han, S., Li, R., Goldberg, I. J., Welch, C. L., & Tall, A. R. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.212985 · Cited by 29
Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice
Moerland, M., Samyn, H., van Gent, T., Jauhiainen, M., Metso, J., van Haperen, R., Grosveld, F. G., van Tol, A., & de Crom, R. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700020-jlr200 · Cited by 25
Dullaart, R. P. F., Perton, F. G., Kappelle, P. J. W. H., de Vries, R., Sluiter, W. J., & van Tol, A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.019 · Cited by 20
Oxpholipin 11D: An Anti-Inflammatory Peptide That Binds Cholesterol and Oxidized Phospholipids
Ruchala, P. P., Navab, M., Jung, C., Hama-Levy, S., Micewicz, E. D., Luong, H. T., Reyles, J. E., Sharma, S. K., Waring, A. J., Fogelman, A. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010181 · Cited by 8
Self-citation
Cited by
Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
“in reverse cholesterol transport (RCT) [218].”
InfluentialEffects of dalcetrapib in patients with a recent acute coronary syndrome
Schwartz, G. G., Olsson, A. G., Abt, M., Ballantyne, C. M., Barter, P. J., Brumm, J., Chaitman, B. R., Holme, I. M., Kallend, D., Leiter, L. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206797 · Cited by 2,022
Overview of Epidemiology and Contribution of Obesity to Cardiovascular Disease
Bastien, M., Poirier, P., Lemieux, I., & Després, J.-P. (2014) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.10.016 · Cited by 1,125
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 459
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
Lobatto, M. E., Fuster, V., Fayad, Z. A., & Mulder, W. J. M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3578 · Cited by 423
Metadata
- Authors
- Navab, M., Reddy, S. T., Van Lenten, B. J., & Fogelman, A. M.
- Venue
- Nature Reviews Cardiology
- Published
- 2011-02-08
- Volume
- 8
- Issue
- 4
- Pages
- 222-232
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- OpenAlex
- W2042344342
- Cited by
- 656
- References
- 106
- FWCI
- 10.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.